Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES BIOCON ALKEM LABORATORIES/
BIOCON
 
P/E (TTM) x 33.4 36.7 91.0% View Chart
P/BV x 4.3 4.1 105.1% View Chart
Dividend Yield % 1.1 0.2 613.7%  

Financials

 ALKEM LABORATORIES   BIOCON
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
BIOCON
Mar-22
ALKEM LABORATORIES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs4,068424 959.1%   
Low Rs2,671315 848.3%   
Sales per share (Unadj.) Rs889.468.2 1,304.7%  
Earnings per share (Unadj.) Rs140.58.2 1,724.3%  
Cash flow per share (Unadj.) Rs166.014.9 1,111.4%  
Dividends per share (Unadj.) Rs34.000.50 6,800.0%  
Avg Dividend yield %1.00.1 745.7%  
Book value per share (Unadj.) Rs722.468.5 1,054.0%  
Shares outstanding (eoy) m119.571,200.60 10.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.85.4 69.9%   
Avg P/E ratio x24.045.3 52.9%  
P/CF ratio (eoy) x20.324.7 82.0%  
Price / Book Value ratio x4.75.4 86.5%  
Dividend payout %24.26.1 394.4%   
Avg Mkt Cap Rs m402,868443,622 90.8%   
No. of employees `000NANA-   
Total wages/salary Rs m19,62718,801 104.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,34281,840 129.9%  
Other income Rs m1,6276,891 23.6%   
Total revenues Rs m107,96888,731 121.7%   
Gross profit Rs m20,38013,827 147.4%  
Depreciation Rs m3,0408,142 37.3%   
Interest Rs m524676 77.5%   
Profit before tax Rs m18,44311,900 155.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6402,115 77.5%   
Profit after tax Rs m16,8039,785 171.7%  
Gross profit margin %19.216.9 113.4%  
Effective tax rate %8.917.8 50.0%   
Net profit margin %15.812.0 132.2%  
BALANCE SHEET DATA
Current assets Rs m84,35483,823 100.6%   
Current liabilities Rs m48,05338,280 125.5%   
Net working cap to sales %34.155.6 61.3%  
Current ratio x1.82.2 80.2%  
Inventory Days Days42101 41.7%  
Debtors Days Days6592 70.5%  
Net fixed assets Rs m43,245117,184 36.9%   
Share capital Rs m2396,003 4.0%   
"Free" reserves Rs m86,13476,281 112.9%   
Net worth Rs m86,37382,284 105.0%   
Long term debt Rs m9439,985 0.2%   
Total assets Rs m127,599201,007 63.5%  
Interest coverage x36.218.6 194.7%   
Debt to equity ratio x00.5 0.2%  
Sales to assets ratio x0.80.4 204.7%   
Return on assets %13.65.2 260.9%  
Return on equity %19.511.9 163.6%  
Return on capital %21.910.3 213.3%  
Exports to sales %18.70-   
Imports to sales %07.8 0.0%   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNA6,360 0.0%   
Fx inflow Rs m19,9248,885 224.2%   
Fx outflow Rs m3,9116,360 61.5%   
Net fx Rs m16,0132,525 634.2%   
CASH FLOW
From Operations Rs m11,11011,766 94.4%  
From Investments Rs m-14,351-16,991 84.5%  
From Financial Activity Rs m3,7962,421 156.8%  
Net Cashflow Rs m580-2,433 -23.8%  

Share Holding

Indian Promoters % 57.2 39.7 144.1%  
Foreign collaborators % 0.0 21.0 -  
Indian inst/Mut Fund % 20.2 23.6 85.7%  
FIIs % 4.5 15.8 28.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.8 39.4 108.8%  
Shareholders   79,721 369,816 21.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on ALKEM LABORATORIES vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Biocon Share Price Performance

Period ALKEM LABORATORIES Biocon S&P BSE HEALTHCARE
1-Day 0.08% -1.02% -0.45%
1-Month -5.51% 5.15% -2.33%
1-Year -9.77% -23.05% -5.95%
3-Year CAGR 15.47% -0.39% 20.82%
5-Year CAGR 9.22% -11.26% 11.40%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.2% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Biocon paid Rs 0.5, and its dividend payout ratio stood at 6.1%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.